These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 4154313)

  • 1. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on the haemodynamic response of hypertensive patients treated with a beta blocker (ICI 66082).
    Amery A; Billiet L; Joossens JV; Meekers J; Reybrouck T; Van Mieghem W
    Acta Clin Belg; 1973; 28(5):358-63. PubMed ID: 4149691
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of metoprolol and trichlormethiazide in hypertension.
    Stokkeland OM; Sangvik K; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term administration of trimepranol in young men with labile borderline hypertension and its influence on plasma renin activity (author's transl)].
    Slabý A; Dosková M; Jirák R; Pavlát J; Urbánek J; Reisenauer R
    Sb Lek; 1975 Apr; 77(4):107-11. PubMed ID: 238278
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of SD/1601 on tolerance to exercise in patients with angina.
    Maggi A; Mariani G; Tettamanti R; Tallone G
    G Ital Cardiol; 1975; 5(1):142-8. PubMed ID: 235477
    [No Abstract]   [Full Text] [Related]  

  • 6. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A
    Ther Hung; 1986; 34(3):171-4. PubMed ID: 2894722
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Beta receptors and renin release.
    Amery A; Billiet L; Fagard R
    N Engl J Med; 1974 Jan; 290(5):284. PubMed ID: 4148766
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.
    Hansson L; Aberg H; Jameson S; Karlberg B; Malmcrona R
    Acta Med Scand; 1973 Dec; 194(6):549-50. PubMed ID: 4149321
    [No Abstract]   [Full Text] [Related]  

  • 10. Celiprolol--a better beta blocker?
    Drug Ther Bull; 1992 Apr; 30(9):35-6. PubMed ID: 1350530
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with carvedilol.
    Moser M
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S16-20. PubMed ID: 8098064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyldopa (Aldomet) in combination with timolol (Blocadren) in the treatment of hypertension.
    Seedat YK
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):10-8. PubMed ID: 8279
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
    Ostapiuk FE; Khvoĭnitskiĭ VA
    Sov Med; 1984; (5):87-9. PubMed ID: 6147019
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 15. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
    Bertel O; Conen D; Renggli I
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
    [No Abstract]   [Full Text] [Related]  

  • 16. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of the beta-blocker chlorpropanol (tobanum) in hypertension patients].
    Sirakova V; Penkov N; Kaponov Kh
    Vutr Boles; 1986; 25(1):35-41. PubMed ID: 2872751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of essential hypertension using a new beta-receptor blockader (timolol maleate) combined with hydrochlorothiazide].
    Heinze A; Wessels F
    Verh Dtsch Ges Inn Med; 1974; 80():272-4. PubMed ID: 4156115
    [No Abstract]   [Full Text] [Related]  

  • 19. A preliminary clinical trial of Prazosin: a new oral antihypertensive agent.
    Bolli P; Simpson FO
    N Z Med J; 1974 May; 79(516):969-72. PubMed ID: 4152750
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.